Study of Urinary Podocalyxin As an Early Biomarker in Diabetic Nephropathy

Assessment of Urinary Podocin Level as an Early Indicator in Diabetic Nephropathy

Study of The Podocalyxin as An Early Marker for Diabetic Nephropathy and Its Correlation with Stages of Diabetic Nephropathy in A Sample of Egyptian Patients with T2DM

FETUIN A AS AN EARLY MARKER OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Role of Kidney Injury Molecule-1 and β2-Microglobulin in Early Diagnosis of Diabetic Nephropathy

Osteopontin As A Marker of Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus

Study of Lipoprotein-Associated Phospholipase A2 as a Potential Biomarker for Diabetic Kidney Disease in Type 2 Diabetes

NEW MARKER FOR THE EARLY DIAGNOSIS OF NEPHROPATHY ASSOCIATED WITH TYPE II DIABETES MELLITUS

Cystatin-C as an early marker of diabetic nephropathy in diabetic patients

Study of Plasma Copeptin as a Predictor of Diabetic Nephropathy in Type 2 Diabetic Patients